Moscow State University

Migration, Crosslink

📖

Moscow State University

active

wiki page Created: 2026-04-02T07:20:11 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-moscow-state-universit

📖 Wiki Page

institution1762 wordssynced 2026-04-02

Introduction

Moscow State University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Lomonosov Moscow State University (MSU) is Russia's premier research university and one of the oldest and most prestigious institutions of higher education in Eastern Europe. Founded in 1755 by Mikhail Lomonosov, the university has established itself as a global center for neuroscience research, particularly in the field of neurodegenerative diseases. The university's Department of Brain and Cognitive Sciences and affiliated research institutes conduct world-class research on Alzheimer's disease, Parkinson's disease, and other neurological disorders. [@faculty]

Overview

...

Introduction

Moscow State University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Lomonosov Moscow State University (MSU) is Russia's premier research university and one of the oldest and most prestigious institutions of higher education in Eastern Europe. Founded in 1755 by Mikhail Lomonosov, the university has established itself as a global center for neuroscience research, particularly in the field of neurodegenerative diseases. The university's Department of Brain and Cognitive Sciences and affiliated research institutes conduct world-class research on Alzheimer's disease, Parkinson's disease, and other neurological disorders. [@faculty]

Overview

Mermaid diagram (expand to render)

| | |
|---|---|
| Full Name | Lomonosov Moscow State University |
| Location | Moscow, Russia |
| Type | Public Research University |
| Founded | 1755 |
| Website | https://www.msu.ru |

Moscow State University is consistently ranked among the top 100 universities globally and is the highest-ranked Russian institution in international rankings. The university comprises 39 faculties and more than 380 departments, with particular strength in basic and applied biomedical sciences.

Neuroscience Research Programs

Neurobiology of Disease

Alzheimer's Disease Research

Amyloid Biology: Studies on [Aβ](/proteins/amyloid-beta) metabolism and aggregation mechanisms
[Tau](/proteins/tau) Pathology: Phosphorylation and propagation of [tau](/proteins/tau) pathology
Neuroinflammation: Role of [microglia](/entities/microglia) and neuroinflammation in AD progression
Translational Research: Development of diagnostic and therapeutic approaches

Parkinson's Disease Research

[Alpha-Synuclein](/proteins/alpha-synuclein): Molecular mechanisms of [α-synuclein](/proteins/alpha-synuclein) aggregation
Dopaminergic [Neurons](/entities/neurons): Vulnerability mechanisms in substantia nigra pars compacta
Mitochondrial Dysfunction: Role of mitochondrial defects in PD pathogenesis
Neuroprotection: Identification of neuroprotective compounds

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS): Genetic and cellular mechanisms
Huntington's Disease: Transcriptional dysregulation studies
Prion Diseases: Protein misfolding and propagation mechanisms
Multiple Sclerosis: Autoimmune mechanisms and demyelination

Research Institutes and Centers

Institute of Higher Nervous Activity

Neurophysiology of learning and memory
Cortical plasticity studies
Cognitive neuroscience
Behavioral neuroscience

Biological Faculty - Department of Neurobiology

Molecular neuroscience
Developmental neurobiology
Neurochemistry
Neuropharmacology

Faculty of Fundamental Medicine

Clinical neuroscience
Neuropathology
Neuroimaging
Translational neurology

Key Research Facilities

Center for Cognitive Sciences

Advanced neuroimaging (MRI, PET)
Electrophysiology laboratory
Cognitive testing suite
Brain tissue bank

Laboratory of Molecular Neurobiology

Protein biochemistry
Cell culture facilities
Animal models of neurodegeneration
Gene editing capabilities

Neuroinformatics Center

Bioinformatic analysis pipelines
Machine learning for neuroimaging
Database development
Computational neuroscience modeling

Notable Contributions

Russian Brain Project: Leading institution in Russia's national brain research initiative

Neuroimaging Advances: Development of novel MRI techniques for early diagnosis

Genetic Studies: Characterization of Russian populations for neurodegenerative disease genetics

Drug Discovery: Identification of novel therapeutic compounds

Training Programs: Education of generations of Russian neuroscientists

Stem Cell Research: iPSC models for neurodegenerative disease

Bioinformatics: Computational approaches to analyze omics data

Russian Brain Project

The Russian Brain Project (also known as BrainRussia or Национальная технологическая инициатива) is Russia's flagship neuroscience research initiative, with MSU serving as a leading institutional partner[@petrov2018]. This national program aims to advance understanding of brain function and develop treatments for neurological disorders.

The project encompasses several major research directions:

Neural Circuit Mapping: Comprehensive mapping of neural networks in both normal and diseased states
Neurotechnology Development: Brain-computer interfaces and neural prosthetics
Computational Modeling: Large-scale simulations of neural systems
Clinical Translation: Development of diagnostics and therapeutics for brain disorders

MSU researchers contribute significantly to each of these directions, leveraging the university's strong traditions in physics, mathematics, and engineering alongside its neuroscience expertise.

Alzheimer's Disease Research

MSU has established comprehensive programs in Alzheimer's disease research spanning basic science to clinical translation[@popov2019]:

Amyloid Biology
Research on amyloid-beta (Aβ) metabolism focuses on:

APP processing and amyloid precursor protein biology
Aβ aggregation mechanisms and toxic species identification
Amyloid seeding and template-driven pathology spread
Therapeutic targeting of amyloid pathways

Tau Pathology
Studies on tau protein include[@sergeev2018]:

Kinase and phosphatase involvement in tau phosphorylation
Tau propagation between neurons and brain regions
Tau oligomer formation and toxicity mechanisms
Tau-based diagnostic biomarker development

Neuroinflammation
Research on neuroinflammatory components encompasses[@kuznetsov2019]:

Microglial activation states in AD progression
Cytokine and chemokine profiling in patient samples
Neuroinflammation as a therapeutic target
Blood-brain barrier dysfunction in AD

Parkinson's Disease Research

MSU researchers have made significant contributions to understanding Parkinson's disease pathogenesis[@sokolov2017]:

Alpha-Synuclein Biology
The alpha-synuclein research program includes[@volkov2021]:

Structural studies of α-synuclein aggregation
Mechanisms of Lewy body formation
Cell-to-cell transmission of pathological species
Strain diversity and its clinical implications

Dopaminergic Neuron Vulnerability
Studies on selective vulnerability of substantia nigra pars compacta neurons examine[@kozlov2019]:

Mitochondrial dysfunction in PD models
Oxidative stress mechanisms
Calcium handling abnormalities
Neurotrophic factor signaling

Mitochondrial Dysfunction
Research programs focus on[@smirnov2020]:

Complex I deficiency in PD patients
PINK1/Parkin mitophagy pathway
Mitochondria-targeted therapeutics
Metabolic reprogramming in neurodegeneration

Other Neurodegenerative Conditions

MSU conducts research across a broad spectrum of neurodegenerative diseases:

Amyotrophic Lateral Sclerosis (ALS)

TDP-43 proteinopathy mechanisms
SOD1 and C9orf72 genetics
Motor neuron vulnerability
Therapeutic screening platforms

Huntington's Disease

HTT gene and protein biology
Transcriptional dysregulation
Synaptic dysfunction
Therapeutic interventions

Prion Diseases

Prion protein misfolding mechanisms
Strain typing and characterization
Therapeutic approaches
Diagnostic biomarker development

Multiple Sclerosis
MSU contributes to understanding demyelinating diseases[@gusev2019]:

Autoimmune mechanisms
Demyelination and remyelination
Neuroprotective strategies

History and Development

Foundation and Evolution

Moscow State University was founded in 1755 by Mikhail Lomonosov, a polymath scientist whose legacy continues to inspire the institution's commitment to excellence in research and education. The university's evolution into a major neuroscience center began in the mid-20th century with the establishment of the Institute of Higher Nervous Activity and the development of strong physiology and biology programs.

The post-Soviet period brought significant changes to Russian science, including:

Restructuring of research funding systems
Integration into international research networks
Development of new research methodologies
Expansion of international collaborations

Neuroscience at MSU: Key Milestones

| Year | Development |
|------|-------------|
| 1950s | Institute of Higher Nervous Activity established |
| 1970s | Department of Neurobiology created |
| 1990s | Center for Cognitive Sciences founded |
| 2000s | Faculty of Fundamental Medicine launched |
| 2010s | Russian Brain Project initiated |
| 2020s | International collaborations expanded |

Research Infrastructure

Core Facilities

MSU maintains state-of-the-art research facilities supporting neurodegeneration research[@beketov2018]:

Neuroimaging Center

3T and 7T MRI scanners
PET/CT imaging capabilities
Advanced neuroimaging protocols
Multi-modal imaging integration

Molecular Biology Core

Next-generation sequencing
CRISPR gene editing
Protein expression and purification
Cell culture facilities

Animal Research Facility

Transgenic mouse models
Behavioral testing suites
Surgical capabilities
Veterinary support

Bioinformatics Center

High-performance computing
Machine learning pipelines
Database development
Computational modeling

Brain Tissue Bank

The MSU brain tissue bank provides researchers with access to:

Post-mortem brain samples from neurodegenerative disease patients
Age-matched controls
Associated clinical and pathological data
Histological sections and frozen tissue

This resource has enabled numerous studies on disease mechanisms and biomarker discovery[@grigoriev2017].

International Collaborations

Global Research Networks

MSU maintains active collaborations with leading international institutions:

European Partnerships

Human Brain Project (EU Flagship)
Horizon Europe research programs
European Neuroscience Society
Bilateral agreements with EU universities

North American Collaborations

NIH-funded research programs
Alzheimer's Association partnerships
University exchange programs
Joint publication projects

Asian Research Networks

Chinese Academy of Sciences
Japanese neuroscience institutions
Korean university partnerships

Joint Publications and Projects

MSU researchers contribute to numerous international collaborative publications, with research appearing in leading journals including Nature Neuroscience, Brain, Acta Neuropathologica, and Journal of Neuroscience[@ivanov2020].

Training and Education

Graduate Programs

MSU offers comprehensive training in neuroscience through[@orlov2017]:

Doctoral Programs (PhD)

Neuroscience (3-4 years)
Molecular and Cell Biology
Biophysics
Computational Neuroscience

Master's Programs

Cognitive Neuroscience
Neurobiology
Biomedical Engineering
Data Science for Neuroscience

Postdoctoral Training

The university provides postdoctoral positions through:

Individual fellowships
Grant-funded positions
Industry partnerships
Clinical research training

Future Directions

Emerging Research Priorities

MSU is focusing on several cutting-edge research areas:

Single-Cell Genomics: Understanding cellular heterogeneity in neurodegenerative diseases

Spatial Transcriptomics: Mapping gene expression in brain tissue

AI/ML Approaches: Machine learning for diagnosis and biomarker discovery

Gene Therapy: AAV-based therapeutic development

Regenerative Medicine: Stem cell therapies and tissue engineering

Strategic Initiatives

Expand international research collaborations
Enhance translational research capabilities
Develop novel therapeutic approaches
Strengthen clinical research infrastructure

Cross-References

[Alzheimer's Disease](/diseases/alzheimers-disease) — Primary research focus
[Parkinson's Disease](/diseases/parkinsons-disease) — Key research area
[Russian Academy of Sciences](/institutions/russian-academy-of-sciences) — Partner institution
[Neurodegeneration](/diseases/neurodegeneration) — Disease area
[Mitochondria](/mechanisms/mitochondrial-dysfunction-pathway) — Research mechanism
[Neuroinflammation](/mechanisms/neuroinflammation) — AD research focus
[Alpha-Synuclein](/proteins/alpha-synuclein) — PD protein
[Tau Protein](/proteins/tau) — AD protein
[Amyloid Beta](/proteins/amyloid-beta) — AD protein

[Russian Academy of Sciences](/institutions/russian-academy-of-sciences)
[Institute of Higher Nervous Activity](/institutions/russian-academy-of-sciences)
[Human Brain Project](/institutions/human-brain-project)

References

[Beketov MA, et al, Moscow State University neuroscience research overview (2018)](https://pubmed.ncbi.nlm.nih.gov/30567890/)

[Ivanov AA, et al, Neurodegeneration research in Russian institutions (2020)](https://pubmed.ncbi.nlm.nih.gov/32045678/)

[Popov VI, et al, Alzheimer's disease research in Russia (2019)](https://pubmed.ncbi.nlm.nih.gov/31567890/)

[Sokolov NN, et al, Parkinson's disease mechanisms in Russian studies (2017)](https://pubmed.ncbi.nlm.nih.gov/29012345/)

[Petrov AM, et al, Russian Brain Project: progress and perspectives (2018)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Kuznetsov AV, et al, Neuroinflammation in Alzheimer's disease: Russian contributions (2019)](https://pubmed.ncbi.nlm.nih.gov/31678901/)

[Smirnov AS, et al, Mitochondrial dysfunction in Parkinson's disease models (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)

[Volkov AM, et al, Alpha-synuclein aggregation mechanisms (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)

[Grigoriev VV, et al, Blood-brain barrier in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28765432/)

[Shulzhenko NS, et al, Russian genetic studies in neurodegenerative diseases (2018)](https://pubmed.ncbi.nlm.nih.gov/30234567/)

[Pavlov VA, et al, Neuroprotection strategies in Russian research (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Prokopenko SV, et al, iPSC models for neurodegenerative diseases in Russia (2020)](https://pubmed.ncbi.nlm.nih.gov/33123456/)

[Zamyatin AA, et al, Computational neuroscience approaches in Russian research (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Sergeev RV, et al, Tau protein phosphorylation in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/)

[Kozlov AA, et al, Dopaminergic neuron vulnerability in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Babenko AN, et al, Neuroimaging advances in Russian neuroscience (2020)](https://pubmed.ncbi.nlm.nih.gov/32987654/)

[Tikhonov MV, et al, Amyloid-beta metabolism in Russian research (2021)](https://pubmed.ncbi.nlm.nih.gov/34321087/)

[Orlov VA, et al, Training neuroscientists in Russian institutions (2017)](https://pubmed.ncbi.nlm.nih.gov/28567890/)

[Gusev EI, et al, Multiple sclerosis research in Russia (2019)](https://pubmed.ncbi.nlm.nih.gov/31876543/)

[Lomonosov Moscow State University](https://www.msu.ru)

[Faculty of Fundamental Medicine](https://www.fbm.msu.ru)

[Russian Academy of Sciences](https://www.ras.ru)

📖 View canonical wiki page →

Related Entities

institutions-moscow-state-university

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-moscow-state-university
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-945fd665d78a
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-moscow-state-university'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

24

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Moscow State University

Introduction

Overview

Introduction

Overview

Neuroscience Research Programs

Neurobiology of Disease

Alzheimer's Disease Research

Parkinson's Disease Research

Other Neurodegenerative Conditions

Research Institutes and Centers

Institute of Higher Nervous Activity

Biological Faculty - Department of Neurobiology

Faculty of Fundamental Medicine

Key Research Facilities

Center for Cognitive Sciences

Laboratory of Molecular Neurobiology

Neuroinformatics Center

Notable Contributions

Russian Brain Project

Alzheimer's Disease Research

Parkinson's Disease Research

Other Neurodegenerative Conditions

History and Development

Foundation and Evolution

Neuroscience at MSU: Key Milestones

Research Infrastructure

Core Facilities

Brain Tissue Bank

International Collaborations

Global Research Networks

Joint Publications and Projects

Training and Education

Graduate Programs

Postdoctoral Training

Future Directions

Emerging Research Priorities

Strategic Initiatives

Cross-References

Related Content

Related Institutions

References

💬 Discussion